Economic Cost of Current and Alternative Models of Multidisciplinary Care of Juvenile‐Onset Huntington's Disease
Open Access
- 11 November 2025
- journal article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 13 (4) , 964-972
Abstract
Background: Multidisciplinary care has been advocated for Juvenile‐onset Huntington's Disease but there has been no detailed analysis of this. Objectives: To evaluate the current economic costs of providing health care for patients with Juvenile‐onset Huntington's disease (JoHD) and to model the effects and economic costs of providing a multidisciplinary team (MDT) approach. Methods: Patients were recruited through the patients’ organization, the Huntington's Disease Association, and specialist Huntington's disease clinics. Thirty‐three adapted Client Service Receipt Inventories were completed following either a telephone or in‐person interview. The effects of delivering two models of providing a systematic MDT approach, traditional in‐person MDT and digital MDT were assessed. Results: The overall mean JoHD cost to the NHS per year (2020) was £126,966 which varied according to disease severity, costing just under £11,000 in mild disease, £132,419 in moderate disease, and £221,797 in advanced JoHD. The proportion of indirect costs to families and carers was 64% for mild disease and 17% for advanced disease. Assuming a 50% reduction in health care professionals seen, the alternative models saw reduction costs of £2490 and £2730, respectively. Conclusion: We document the high cost of care in JoHD, particularly as the disease progresses towards the later stages. We present estimates from modeling the effects of providing a systematic MDT approach to the care of patients and families with JoHD. These data have clear implications in the consideration of future JoHD models of care in an increasingly digital age and can be developed further as disease modifying treatments become available.Keywords
Funding Information
- National Institute for Health and Care Research (PB‐PG‐112‐29056)
This publication has 16 references indexed in Scilit:
- Variation in the reported prevalence of Huntington’s disease: a systematic review and guide to interpretationJournal of Neurology, 2025
- Economic burden of Huntington’s disease: A systematic reviewJournal of Huntington's Disease, 2025
- The known burden of Huntington disease in the North of Scotland: prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular eraJournal of Neurology, 2021
- The societal cost of Huntington's disease: are we underestimating the burden?European Journal of Neurology, 2016
- Huntington diseaseNature Reviews Disease Primers, 2015
- Huntington’s Disease: Current Epidemiology and Pharmacological Management in UK Primary CareNeuroepidemiology, 2011
- Observing Huntington's disease: the European Huntington's Disease Network's REGISTRYJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Huntington's diseaseBMJ, 2010
- Huntington's diseaseThe Lancet, 2007
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993